Clinical Trial Update: sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC [Phase 1]

View source ↗

Summary

This is a Phase 1 trial evaluating sEphB4-HSA with radiotherapy plus chemotherapy or cetuximab in locally advanced head and neck squamous cell carcinoma. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• ERBITUX (cetuximab)
• sEphB4-HSA

Snippet

Sponsor: University of Colorado, Denver | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 1 | Status: COMPLETED